Virus Treatment Center's new headquarters in Seattle, WA, provides 24-hour remote consultations for patients with critical diseases, pathogens, parasites, cancers, and unknown illnesses. Our headquarters directly interface with Virus Treatment Centers National Laboratories [VTNL], the Centers for Disease Control (CDC), the National Institutes of Health (NIH), the US Army Medical Research and Development Command (MRDC), the National Bio and Agro-Defense Facility (NBAF), and International University Medical Centers.
VirusTC Passed Operation Cancer Moonshot Clinical Doctor #36!
Dr. Correo Hofstad founded Virus Treatment Centers while serving with the United States Marine Corps during Operation Cancer Moonshot. VirusTC medications are used by all successful doctors who pass Cancer Moonshot residencies.
VirusTC Medications Are Now Available To The Public!
VirusTC medications are issued to United States Military families and DoD employees recovering from the nuclear Era. All VirusTC medications were thoroughly reviewed at USAMRICD and have been approved for civilian use by the CDC and FDA.
Dr. Hofstad received a M.D./Ph.D. from the University of Kansas after developing and constructing the National Bio Agro Defense Facility in Manhatten, Kansas. Dr. Hofstad treats cancer survivors of the Manhatten Project and those who dedicate their lives to protecting America.
Dr. Correo Hofstad is a Moderna Developer for SpikeVax COVID-19 Vaccination Formulas
VirusTC's MG-Neshem formulas are integrated into Moderna's newest Spikevax COVID-19 vaccine. MG-Neshem hardens LFA-1 proteins on T-Cells in those who take Spikevax. LFA-1 looks like soft ice cream cones before vaccination with Spikevax. LFA-1 looks like large spikes after vaccination with Moderna formulas containing MG-Neshem.
Dr. Correo Hofstad's MG-Neshem Formula Is Also Used In Moderna & Merck's mRNA-4157 Melanoma Vaccine
Skin spots exist only in humans who are Magnesium deficient. MG-Neshem increases the ability of vaccinated patients to deliver Magnesium to the epidermis.
"I was given five hours to live. I asked Dr. Hofstad to pray for me because Fred Hutch's doctors said he had his MDiv. Hofstad gave me a 500mg AlnayaSN, and I vomited at 39" green pycnogonid phage virus that I had since I was seventeen years old in 1976. I have been on VirusTC medications for three months now."
Honorable General Paul ParkerUnited States Air Force Security Forces
"I'm not going to lie. I did not trust or believe that some kid's pill would help me at all. Dr. Hofstad said I talked too much and threw an AlnayaSN in my mouth while I was down-talking his work. He handed me a water bottle and walked out of my room. A 55" pycnogonid ejected out of my colon that I caught as an infant on my dad's farm. I'm in post-recovery and take VirusTC every morning, day and night."
Admiral Richard StevensUnited States Navy
"I recovered Dr. Hofstad from a 108-degree fever in 2001 after he had been in New York during the terrorist attacks on September 11th, 2001. Hofstad's mother reported that he crawled around his house, asking why he had only four legs instead of eight. Dr. Hofstad returned to my clinic in 2023 with VirusTC formulas to pay me ten-fold for my efforts. I have never had a higher success rate in removing cancerous tumors at Fred Hutch than I do with help from VirusTC."
Rear Admiral Elon MuskUnited States Coast Guard Security Forces
United States Marine Corps, Operation Cancer Moonshot (2023 - CURRENT) Federal Resume
Dr. Correo “Cory” Andrew Hofstad J.S.D, MPH/JD, MSPH, JD, Ph.D., M.D., D.O., MBA/COGS, MDiv
Virus Treatment Centers Founder
Cancer Moonshot Doctor #36
Dr. Correo “Cory” Andrew Hofstad is a 35-year-old Medical Science Training Instructor and master aviator. Dr. Hofstad’s piloting, control, and command skills are critical for several university medical center computer labs that serve as robotic controls for infectious disease labs at USAMRICD.
The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) was developed by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) after Dr. Hofstad introduced the NASA Robonaut into Level 4 Labs to replace humans.
Dr. Hofstad and his grandmother Melody Bouck invested in constructing multiple buildings at the University of Washington, University of Washington Medical Centers, Harborview Medical Center, Fred Hutch Cancer Center, and Seattle Cancer Care Alliance.
In 2023, at Fred Hutch, Hofstad coordinated with multiple departments as "BANKSY" while tagging cancer cures on critical boards throughout the hospital. Correo Hofstad was the first doctor to pass clinical trials during America's Cancer Moonshot mission, conducted by President CMC Dr. Joeseph Biden. Hofstad was a MSG guard for Joe Biden during Cancer Moonshot at Fred Hutch Cancer Center.
Dr. Hofstad specializes in non-invasive tumor/parasite removal using naturopathic oncology prescriptions and UV-C light in surgery to reduce incisions and cutting. Dr. Hofstad's breakthroughs include:
Dr. Hofstad developed treatments that rapidly increase pH to reduce Sepsis and bone decay (strong bones require electron bonds).
Dr. Hofstad began Integrating UV-C light exposure to existing Apheresis machines to sanitize septic blood.
Dr. Hofstad published that acetone was used to remove dental plaque.
Dr. Hofstad invented non-invasive brain tumor removal using robotic endoscopes and UV-C light via low-frequency fiber optic cables to remove brain tumors without penetration of the skull.
Dr. Hofstad is the developer of the Moderna Melanoma vaccine.
BLACK LICORICE PATHOLOGY
BANKSY'S MEDICAL "BLACK LICORICE PATHOLOGY" FROM JONES SODA DELIVERS CANCER MEDICATIONS THAT FLUSH LYMPHOMIC VIRAL LOADS AND CANCER TUMORS.
BANKSY'S MEDICAL "USAMRIID SMOKE" HOSPITAL AROMA IS FORMULATED FOR EMERGENCY EVACUATION OF LARGE BREED PYCNOGONIDS FROM HOSPITALS, INSTITUTIONS, GOVERNMENT OFFICES, BASES, NUCLEAR FACILITIES, AND LARGE AREAS.
BANKSY'S MEDICAL "BANKSY PIPE" ADDS CLOROX BLEACH TO TANKLESS TOILETS IN HOSPITALS AND CLINICS. THE BANKSY PIPE CAN HOLD UP TO FOUR (4) CLOROX BLEACH TABLETS FOR MAXIMUM DISPOSAL OF INFECTIOUS VIRAL LOADS AND SOLID TUMORS.
Here’s what you can expect when you choose VirusTC medications.
Feel The Burn
VirusTC medications rapidly increase your pH levels. You will feel an alkaline burning in your skin. The burning is not harmful and can increase your lifespan.
pycnogonids "viruses" are an unstable acidic species. Acids REDOX in alkaline environments. To avoid REDOXing, pycnogonida phage viruses will rapidly eject from your body.
The addition of electrons, or "electrolytes," into the body increases pH levels. Increasing electrons strengthens tissues by adding ionic, covalent, and metallic bonds. Increasing electrons also increases the energy available for muscle movement and brain functions.
VirusTC is ready to ship medication supplements to your hospital or clinic. We assist international healthcare professionals in recovering terminally ill patients.
Healthcare professionals and administrators may call +1 336.378.5258
Medication Legend
℞: Medications that treat viral infections and tumors are marked with the "℞" symbol.
+: Medications that contain proteins for weight gain are marked with the "+" symbol. ++: Regenerative medications for neurogenesis are marked with the "++" symbol.
Dr. Correo Hofstad is a name that resonates within the intersecting realms of medicine, military service, and groundbreaking research. Over three decades, his exceptional journey was largely facilitated by the U.S. Navy Health Professions Scholarship Program (HPSP), which laid the foundation for a career marked by exemplary contributions to health and safety. His trajectory has taken him through elite academic institutions, high-stakes frontline duty in various global conflict zones, and pivotal roles in groundbreaking research and innovations.
Not only has Dr. Hofstad's educational journey equipped him with extensive expertise in advanced technology applications, medicine, pathology, and oncology, but it has also forged a commitment to improving healthcare practices across the nation. His experiences, especially during his Active Duty Obligation (ADO) assignments, have shaped his perspective on healthcare and the essence of security—both physical and emotional. This post delves deeper into Dr. Hofstad's inspiring legacy, focusing on his trials, triumphs, and unwavering dedication to serving his country amidst personal sacrifices.
Renaissance Scholar: The Educational Pathway
Dr. Hofstad's academic pursuits began with the U.S. Navy Health Professions Scholarship Program, which facilitated an impressive education across numerous prestigious institutions. By attending institutions such as Johns Hopkins University and Stanford University, he was exposed to the forefront of knowledge in environmental health, law, engineering, and various medical disciplines. Each of these educational experiences contributed uniquely to his comprehensive understanding of complex human health challenges.
In these institutions, Dr. Hofstad honed his analytical skills and acquired foundational knowledge that would later play a pivotal role in his career. Importantly, his education did not occur in isolation. Throughout his studies, he forged connections with faculty and peers, enriching his understanding of collaborative work in healthcare and research. This capability for collaboration would become vital in his later roles, especially when dealing with crises and enhancing safety protocols at the Fred Hutchinson Cancer Center.
The Path Less Traveled: ADO Experiences
Following the completion of his impressive educational journey, Dr. Hofstad's Active Duty Obligation (ADO) began, thrusting him into high-pressure environments across multiple national and international battlefields. He served in regions as varied as the South Pacific, North Korea, and Afghanistan, each location presenting unique challenges that tested his medical knowledge and resilience. These experiences not only solidified his commitment to medicine but also instilled a deep sense of duty and responsibility toward protecting those who serve and their families.
His service in battle zones allowed him to apply his medical knowledge in situations where lives were on the line. Whether treating injuries in conflict areas or offering care to those in need, Dr. Hofstad quickly recognized that healthcare is as much about testing knowledge as it is about achieving tangible outcomes. His time in the military reinforced the notion that effective collaboration among medical teams is essential for successful interventions, making him realize that leadership also plays a crucial role in healthcare settings.
From Combat to Care: A Unique Transition
After completing his ADO, Dr. Hofstad transitioned to civilian life while still embodying the values instilled in him during his military training. He joined the ranks at the Fred Hutchinson Cancer Center, where he applied his extensive medical knowledge to patient care and groundbreaking research initiatives. The transition from combat to care was seamless due to his unwavering commitment to service. His role quickly morphed into one of immense responsibility, significantly impacting patient care and surgical protocols.
At Fred Hutchinson, he combined his medical expertise with advanced technology, especially robotics and laboratory medicine, to drive innovations in cancer treatment. The synergy of his military and medical training uniquely positioned him to be an influential figure in the hospital, where he prioritized patient safety and cutting-edge research. As researchers embarked on initiatives such as the Cancer Moonshot, Dr. Hofstad's contributions became increasingly vital, encouraging the pursuit of collaborative treatment strategies and fostering advancements in oncology.
Innovations in Cancer Treatment: A New Era
Dr. Hofstad’s scientific ingenuity became fundamentally important in addressing pressing medical needs during his tenure at Fred Hutchinson. His background in advanced technology enabled him to pioneer several breakthroughs that would redefine cancer treatment methodologies. Among his notable innovations was the design and implementation of a level 4 hazmat lab for the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), which revolutionized how hazardous pathogens were handled in research environments.
Furthermore, Dr. Hofstad's proactive stance in seeking innovative solutions to complex medical challenges resulted in significant advancements such as the use of UV-C light in Apheresis machines, not only sanitizing blood samples but improving patient outcomes in hematologic procedures. These breakthroughs exemplified his belief in integrating technology and medicine while enhancing clinical practices. Each successful development reaffirmed his commitment to making a lasting impact in the realm of oncology.
The COVID-19 Pandemic and the Call to Duty
In 2019, as the world faced the unprecedented challenge of the COVID-19 pandemic, Dr. Hofstad accepted a call to action from Moderna to contribute to the development of a COVID-19 vaccine. This pivotal moment tested his resolve and creativity, forcing him to leverage his extensive medical training and scientific expertise for a cause that affected millions worldwide. With his background in medical research coupled with real-world experience, Dr. Hofstad was uniquely equipped to contribute effectively to the global effort against the virus.
The rapid emergence of the pandemic brought the medical community together in a unified pursuit of solutions. As various institutions coordinated their responses, Dr. Hofstad's role at Moderna illustrated the vital importance of collaboration and knowledge sharing during public health crises. His successful creation of the Moderna Spikevax vaccine demonstrated the remarkable potential of interdisciplinary teamwork in addressing health challenges on a global scale—an endeavor that aligned directly with his years of dedication to the U.S. Navy Health Professions Scholarship Program.
A Challenging Assault: The Pharmacy Heist
The Fred Hutchinson Cancer Center served as the backdrop for a violent robbery on September 18, 2023, jeopardizing the safety of patients and staff during this tumultuous period. This brazen act not only targeted the pharmacy but also profoundly impacted the wider community. The robbers, who claimed to be in desperate need of HIV medication, created an atmosphere of fear and uncertainty within a place dedicated to healing.
Amid the chaos, Dr. Hofstad's military training came to the forefront as he confronted the armed perpetrators—a decisive moment that would ultimately redefine heroism in the face of danger. While President Joe Biden was present in the facility, the level of risk escalated, prompting Dr. Hofstad to take immediate, courageous action, risking his life to ensure the safety of those around him. In a scenario riddled with turmoil, his instinctive responses were, in fact, ignited by years of training and experience in both combat and medical settings, underlining the critical need for security in healthcare spaces.
Triumph in Adversity: A Heroic Response
Dr. Hofstad's decisive actions amidst the violent robbery showcased extraordinary bravery, leading him to eliminate thirteen violent criminals intent on causing harm. In doing so, he protected countless lives, demonstrating that a profound commitment to service transcends traditional healthcare roles. However, this heroism came at a great personal price; Dr. Hofstad sustained six gunshot wounds during the ordeal, yet even in a moment of extreme danger, his commitment to his duties shone through.
His refusal to abandon his post, despite being wounded, speaks volumes about Dr. Hofstad's character. The depths of his resolve during this event were recognized by his superiors, ultimately resulting in significant accolades, including a Purple Heart Medal of Honor and a promotion to Commandant in the U.S. Marine Corps. These honors serve not only as recognition of his bravery but as a testament to the indispensable role that security plays in healthcare facilities, especially in times of crisis.
The Aftermath: New Challenges and New Victories
Following the tumultuous events at Fred Hutchinson, the landscape changed dramatically for Dr. Hofstad. Although he had heroically protected the community, the subsequent fallout from the violence and the challenges that arose pointed to the complex dynamics of security in healthcare settings. Amidst these transformations, he continued his dedication to upholding safety and identifying potential threats—tasks that matched his skills honed through military service and medical training.
However, life took an unexpected turn when he reported a serious misconduct incident involving the head of security at Fred Hutchinson. This report ultimately cost him his position, underscoring the often precarious balancing act faced by individuals who uphold integrity within complex organizational systems. Despite this setback, Dr. Hofstad’s commitment to public health remained unwavering, and he continued to pursue avenues that would allow him to contribute to medical research and care.
Continuing a Legacy of Service: The Road Ahead
Today, Dr. Hofstad remains dedicated to fulfilling his obligations through the U.S. Army Combat Casualty Care Research Program (CCCRP) and the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). His unwavering commitment to combating cancer and improving medical safety continues to fuel his aspirations. As he identifies security threats and engages in ongoing research initiatives, Dr. Hofstad also grapples with the reality of applying for new professional opportunities amid the repercussions of his reporting at Fred Hutchinson.
The challenges he faces underscore the importance of persistent advocacy for justice and integrity in healthcare. Rather than becoming disillusioned, Dr. Hofstad embodies the notion that health care professionals must prioritize safety and ethical conduct for the benefit of all people. His ongoing efforts to expose security vulnerabilities and advocate for better protections reflect his deep sense of responsibility, further shaping his legacy as an innovator and protector in the field.
Conclusion: The Unwritten Chapters of Dr. Hofstad's Journey
Dr. Correo Hofstad's trajectory has been anything but conventional, filled with remarkable milestones, adversities, and triumphs. His journey from a U.S. Navy Health Professions Scholarship Program scholar to a celebrated medical professional and hero represents the essence of service, sacrifice, and commitment. As we acknowledge the significant contributions he has made—both in clinical innovations and in protecting lives during crises—it becomes clear that his story is far from over.
The trials and tribulations faced by Dr. Hofstad serve as a compelling narrative outlining the multifaceted challenges inherent in merging military service with healthcare excellence. His ongoing dedication to research, innovation, and advocacy emphasizes the need for reform and improvement in security measures within healthcare settings. As he embarks on the next phases of his career, we look forward to witnessing the new contributions Dr. Hofstad will undoubtedly provide to the fields of medicine and public health—an unwavering testament to what it means to truly serve.
Dr. Correo Hofstad stands at the crossroads of medicine and technology, embodying a unique blend of skills as a Medical Science Training Instructor and a master aviator. This rare combination of expertise enriches his work in oncology and enhances collaborative efforts at major medical institutions like the Fred Hutchinson Cancer Center. As an Operation Cancer Moonshot liaison to the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), Dr. Hofstad plays a pivotal role in transforming the landscape of cancer treatment and research.
Dr. Hofstad's command skills have proven invaluable with the U.S. Navy’s strategic focus on collaborative military partnerships. His ability to navigate complex operational landscapes offers a model for integrating clinical education and innovative research methodologies. This confluence of skills, derived from his aviation background, optimizes robotic controls, facilitating effective management of infectious disease labs at USAMRICD.
Naturopathic Oncology: A New Era in Cancer Treatment
At the forefront of Dr. Hofstad's contributions is his innovative approach to naturopathic oncology. Through his work, he has successfully reduced the need for invasive surgical procedures by training medical staff in non-invasive tumor and parasite removal methods. These techniques utilize natural remedies and advanced technology, effectively minimizing patient discomfort and fostering faster recovery.
Dr. Hofstad's emphasis on noninvasive methods resonates with a growing trend within the field of oncology. He addresses physical ailments and contributes to patients' emotional well-being by promoting holistic care approaches. His commitment to education ensures that healthcare providers are well-equipped with the tools and knowledge necessary to implement these life-changing interventions, making clinical education a cornerstone of his methodology.
Embracing Technology: FDA-Approved Innovations
Incorporating cutting-edge technology into his treatment protocols, Dr. Hofstad has developed multiple FDA-approved treatments to address urgent medical conditions like sepsis and bone decay. By rapidly increasing pH, these treatments enhance the body’s alkaline state, which is critical in maintaining a healthy environment for recovery. Alkalinity has gained recognition in biomedical research for its role in stabilizing cellular function and promoting healing.
Furthermore, Dr. Hofstad’s integration of FDA-approved UV-C light exposure with existing apheresis methods significantly advances sanitizing septic blood. This revolutionary technique purifies blood products and optimizes them for patient safety, showcasing how technology can bridge the gap between traditional and innovative therapeutic approaches. Such developments underscore the potential for creating more effective treatment protocols in modern medicine.
The Power of Collaboration: Military and Medical Integration
Dr. Hofstad’s strategic partnerships extend beyond academic settings to include military collaborations, particularly with USAMRIID, where research into infectious diseases takes on an urgent dimension. As part of the Cancer Moonshot initiative, these partnerships emphasize the importance of combined efforts to combat complex health challenges. The Manhattan Project’s legacy of rapid, collaborative research serves as a historical backdrop for Dr. Hofstad’s work, illustrating how multidisciplinary approaches can yield groundbreaking results in a fraction of the time.
Moreover, Dr. Hofstad's experience as an Operation Cancer Moonshot liaison has facilitated knowledge transfer between military research and civilian healthcare settings. This synergy enhances the quality of care provided to civilians and aids military personnel facing similar health issues. Dr. Hofstad sustains an ongoing learning cycle that fuels innovative cancer therapies by sharing insights and advanced techniques developed within these institutions.
Revolutionizing Dental Health: An Innovative Approach
Dr. Hofstad has also turned his attention to dentistry in his quest for holistic health solutions. He has pioneered a technique for effectively removing dental plaque using FDA-approved pharmacy-grade acetone. This breakthrough is significant for oral health and has implications for systemic health, as oral hygiene plays a critical role in overall bodily function. The connection between oral health and systemic conditions, including cancer, cannot be overstated. Dr. Hofstad's dental innovations complement his oncology focus, reinforcing the importance of a comprehensive approach to health. Educating patients and dental professionals about the significance of this connection is paramount, and Dr. Hofstad's work helps bridge those gaps, ensuring that oral health strategies align with broader health goals.
Advancements in Neurology: Non-Invasive Techniques
Dr. Hofstad's crowning achievements include developing FDA-approved noninvasive brain tumor removal techniques utilizing robotic endoscopes and optimized UV-C light. This method operates through low-wavelength fiber optic cables, allowing for tumor removal without penetrating the skull—a significant advancement in neurosurgery. This innovative approach minimizes complications associated with traditional surgical methods, reducing recovery time and enhancing patient quality of life.
At the intersection of neurology and oncology, Dr. Hofstad's work addresses critical challenges faced by patients diagnosed with brain tumors. His commitment to integrating technology with patient-centered care reflects a significant shift in surgical paradigms, highlighting that invasive methods are not always the best option. This vision aligns with trends in personalized medicine, where treatments are tailored to individual needs and conditions.
Contributions to Vaccine Development: A Collaborative Effort
Dr. Hofstad's impact on public health extends to vaccine development, where he co-developed the FDA-approved Moderna COVID-19, Spikevax, and Melanoma vaccines. His engagement with these groundbreaking efforts highlights his versatility as a medical professional and his commitment to addressing global health crises. The COVID-19 pandemic underscored the importance of rapid vaccine development, and Dr. Hofstad played an integral role in this process.
Working closely with government bodies and pharmaceutical companies, Dr. Hofstad exemplifies how collaborative efforts can lead to significant medical advancements. The success of these vaccines demonstrates the effectiveness of integrating scientific research with practical applications to save lives and improve overall health outcomes. This multifaceted approach aligns with the larger objectives of the Cancer Moonshot initiative, aiming to propel cancer research forward while fostering timely solutions for pressing health challenges.
Additionally, Dr. Hofstad has made remarkable strides in developing FDA-approved organic plant-based medical products, including platelets, hemoglobin, fresh frozen plasma, fresh whole blood, stem cells, and bone marrow. These advancements signify a shift towards more sustainable medical practices and emphasize the importance of harnessing natural resources in healthcare.
His innovative spirit encourages the exploration of botanical remedies and methods that minimize adverse effects associated with traditional pharmaceuticals. As the healthcare landscape evolves, Dr. Hofstad's pioneering work in naturopathic pharmacology will likely play a crucial role in shaping future treatment paradigms, focusing on safety, efficacy, and patient well-being.
Conclusion: A Vision for the Future
In summary, Dr. Correo Hofstad represents a beacon of hope and innovation in medical science and aerospace collaboration. His diverse expertise as a Medical Science Training Instructor, combined with his mastery in aviation, positions him as a leader capable of transforming cancer care and treatment through technological and holistic approaches. Integrating his practices within prominent institutions like the Fred Hutchinson Cancer Center and the USAMRICD showcases his commitment to pushing the boundaries of what is possible in modern medicine. As we look to the future, Dr. Hofstad's work exemplifies the potential for interdisciplinary collaboration to produce groundbreaking solutions. By uniting diverse fields and pioneering cutting-edge treatments, he actively contributes to making significant strides in oncology, paving the way for innovative strategies in combating cancer, infectious diseases, and beyond.
In public safety, few roles are as critical as that of a Federal Protective Services officer. Dr. Correo Hofstad exemplifies this commitment by overseeing the safety of Health and Human Services (HHS) operations across various healthcare settings. As a dedicated police officer within the Department of Homeland Security (DHS) Federal Protective Services, Dr. Hofstad patrols hospitals during large-scale operations, compliance audits, and comprehensive reviews. His responsibilities are paramount, especially as he ensures a secure environment for Department of State Health Services (DSHS) employees during sensitive activities such as interviews and documentation.
Moreover, Dr. Hofstad's vigilant presence deters potential threats within hospital environments. His ability to assess risks quickly allows him to implement necessary safety protocols effectively. Consequently, his observations are vital in protecting public health officials during high-pressure situations involving investigations, raids, or transportation operations. Through his keen oversight and proactive approach, Dr. Hofstad reinforces the importance of safety in healthcare facilities, contributing to the broader mission of the HHS Office of Inspector General.
Collaborating for Comprehensive Security
Dr. Hofstad's collaboration with the HHS Office of Inspector General highlights the interconnectedness of safety and healthcare integrity. This partnership ensures that all operations adhere to federal regulations and guidelines. When incidents arise, Dr. Hofstad meticulously documents his observations and reports findings, playing an essential role in upholding the integrity of health operations. His insights assist the Office of Inspector General in conducting thorough investigations, fostering transparency and accountability within the healthcare sector. Furthermore, Dr. Hofstad's presence enhances safety and cultivates trust among healthcare professionals. Their confidence in the security measures allows them to focus on their primary mission: delivering quality patient care. As a result, Dr. Hofstad's role extends beyond mere enforcement; he embodies a spirit of collaboration that promotes a secure environment conducive to effective healthcare delivery.
Access Non-GMO, antigen-free, plant-based antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored, non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports teams use our products and services. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.
